Price & volume screen · refreshed after the Sep 28, 2026 close
Six-month momentum leaders: Healthcare
Large companies with the strongest six-month price performance. Ranks companies worth at least $1B by their six-month split-adjusted return.
| # | Company | Price | 1M | 6M | From high | Mkt cap |
|---|---|---|---|---|---|---|
| 151 | RAPPRapport TherapeuticsHealthcare | $33.44 | −34.2% | +20.1% | −36.3% | $1.60B |
| 152 | AMGNAmgenHealthcare | $418.13 | −4.3% | +19.9% | −5.9% | $226.05B |
| 153 | BDXBecton, Dickinson andHealthcare | $183.83 | −2.3% | +19.0% | −12.5% | $50.07B |
| 154 | SNDASonida Senior LivingHealthcare | $37.61 | −3.6% | +18.8% | −12.7% | $1.81B |
| 155 | ELVNEnliven TherapeuticsHealthcare | $46.01 | −24.0% | +18.5% | −24.8% | $3.37B |
| 156 | MMM3MHealthcare | $169.48 | −5.2% | +18.5% | −7.8% | $87.40B |
| 157 | CRSPCRISPR Therapeutics AGHealthcare | $54.09 | −8.9% | +18.2% | −29.6% | $5.23B |
| 158 | ESTAEstablishment Labs HoldingsHealthcare | $65.34 | −9.0% | +18.1% | −31.7% | $1.95B |
| 159 | ADUSAddus HomeCareHealthcare | $111.91 | −5.2% | +17.6% | −8.8% | $2.09B |
| 160 | LHLabcorp HoldingsHealthcare | $309.57 | −8.0% | +17.2% | −8.8% | $25.11B |
| 161 | STAAStaar Surgical CoHealthcare | $20.87 | −6.8% | +16.7% | −37.4% | $1.05B |
| 162 | COHRCoherentHealthcare | $282.45 | −4.4% | +16.0% | −33.8% | $55.31B |
| 163 | TARSTarsus PharmaceuticalsHealthcare | $76.81 | +6.8% | +15.9% | −15.4% | $3.59B |
| 164 | AUPHAurinia PharmaceuticalsHealthcare | $16.52 | +0.3% | +15.8% | −11.3% | $2.20B |
| 165 | DNLIDenali TherapeuticsHealthcare | $20.98 | −15.0% | +15.5% | −22.9% | $3.35B |
| 166 | IBRXImmunityBioHealthcare | $8.52 | +1.4% | +15.4% | −26.2% | $9.03B |
| 167 | SRRKScholar Rock HoldingHealthcare | $49.13 | −17.1% | +15.3% | −18.2% | $5.98B |
| 168 | DVADaVitaHealthcare | $178.07 | −0.5% | +15.3% | −26.1% | $11.36B |
| 169 | USPHUS Physical TherapyHealthcare | $86.09 | +8.8% | +15.2% | −7.6% | $1.28B |
| 170 | BHCBausch Health CompaniesHealthcare | $5.77 | −8.4% | +14.9% | −27.0% | $2.16B |
| 171 | TDOCTeladoc HealthHealthcare | $5.89 | −7.4% | +14.6% | −39.4% | $1.07B |
| 172 | AGIOAgios PharmaceuticalsHealthcare | $33.42 | −2.5% | +13.6% | −26.5% | $2.00B |
| 173 | GILDGilead SciencesHealthcare | $152.21 | +2.3% | +13.4% | −2.3% | $188.73B |
| 174 | ARWRArrowhead ResearchHealthcare | $65.46 | −26.1% | +13.3% | −26.9% | $9.25B |
| 175 | JNJJohnson & JohnsonHealthcare | $271.95 | +2.3% | +13.1% | −2.3% | $655.37B |
| 176 | INNVInnovAge HoldingHealthcare | $8.89 | −19.4% | +12.4% | −26.6% | $1.21B |
| 177 | HCSGHealthcare Services GroupHealthcare | $20.78 | −9.4% | +12.4% | −17.9% | $1.43B |
| 178 | ZYMEZymeworksHealthcare | $27.12 | −6.5% | +12.2% | −12.7% | $1.94B |
| 179 | PCRXPacira BioSciencesHealthcare | $25.39 | −1.7% | +11.0% | −8.1% | $1.01B |
| 180 | IMNMImmunomeHealthcare | $21.68 | −24.9% | +10.6% | −27.3% | $2.46B |
| 181 | MSAMine Safety IncorporatedHealthcare | $182.32 | −4.9% | +10.3% | −10.2% | $7.03B |
| 182 | BLCOBausch + LombHealthcare | $16.95 | −1.1% | +10.3% | −8.9% | $6.05B |
| 183 | ORICOric PharmaceuticalsHealthcare | $13.27 | −3.4% | +10.0% | −9.4% | $1.38B |
| 184 | BMRNBioMarin PharmaceuticalsHealthcare | $59.46 | −8.9% | +9.8% | −15.3% | $11.51B |
| 185 | PCVXVaxcyteHealthcare | $58.27 | −4.7% | +9.6% | −7.9% | $8.67B |
| 186 | TFXTeleflex IncorporatedHealthcare | $127.38 | −7.5% | +9.6% | −10.3% | $5.40B |
| 187 | NBIXNeurocrine BiosciencesHealthcare | $140.44 | −9.9% | +9.4% | −24.3% | $14.28B |
| 188 | EWEdwards LifesciencesHealthcare | $86.83 | −3.5% | +9.4% | −8.8% | $50.05B |
| 189 | ADMAADMA BiologicsHealthcare | $10.12 | +6.8% | +9.4% | −50.3% | $2.27B |
| 190 | BEAMBeam TherapeuticsHealthcare | $24.23 | −20.5% | +9.2% | −36.1% | $2.50B |
| 191 | BMYBristol-Myers SquibbHealthcare | $63.88 | −4.6% | +9.1% | −6.2% | $130.49B |
| 192 | DNTHDianthus TherapeuticsHealthcare | $87.83 | −21.3% | +8.3% | −24.3% | $4.91B |
| 193 | MLYSMineralys TherapeuticsHealthcare | $25.63 | −1.5% | +8.2% | −45.8% | $2.27B |
| 194 | IRONDisc MedicineHealthcare | $64.92 | −21.4% | +8.0% | −31.0% | $2.49B |
| 195 | CGONCG OncologyHealthcare | $69.61 | −11.9% | +7.7% | −13.7% | $6.17B |
| 196 | PFEPfizerHealthcare | $28.72 | +2.5% | +6.2% | −1.0% | $163.69B |
| 197 | CYTKCytokineticsHealthcare | $66.16 | −15.1% | +5.9% | −24.2% | $9.20B |
| 198 | CLDXCelldex TherapeuticsHealthcare | $31.49 | −22.2% | +3.9% | −29.8% | $2.47B |
| 199 | ZBHZimmer Biomet HoldingsHealthcare | $91.62 | −7.9% | +3.4% | −11.9% | $17.48B |
| 200 | ANIPANI PharmaceuticalsHealthcare | $74.83 | +1.8% | +2.8% | −21.5% | $1.72B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.